The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase
ejection fraction of the heart under echo. All interpretation of data will be sent to Boston
Children's Hospital to be reviewed, which is the primary research center in this study. There
are 5 hospitals participating in this study. The population targeted are children with
moderate heart failure and must be on Ace inhibitors at the time of enrollment. Our outcome
after placing them on Carvedilol is to change their ejection fraction on echo. The patients
will be seen every 1-2 weeks, while we will titrate their medication to a maintenance dose.
Secondary outcome is to increase quality of life, exercise tolerance and decrease their
symptom scores as noted on their questionnaires.